Objectives: This study investigated: (1) the prevalence of HLA-B * 58: 01 carrier in a Vietnamese gout patients treated with allopurinol, and (2) the relationship between this allele and allopurinol-induced cutaneous adverse drug reactions, both mild and severe phenotypes.